Overview of Dr. Eroglu
Dr. Zeynep Eroglu is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 9 years. She is one of 171 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She has more than 90 publications and over 500 citings.
Office
10920 McKinley Dr
Tampa, FL 33612- Is this information wrong?
Education & Training
Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2012 - 2015
University of California (Irvine)Residency, Internal Medicine, 2008 - 2011
David Geffen School of Medicine at UCLAClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2025
FL State Medical License 2015 - 2025
Clinical Trials
- XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma Start of enrollment: 2016 Sep 07
- Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma Start of enrollment: 2018 Jun 27
- Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma Start of enrollment: 2018 Jun 14
- Join now to see all
Publications & Presentations
PubMed
- Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers.Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason J Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwa...> ;Journal of Clinical Oncology. 2024 Mar 20
- Potential Use of ChatGPT for Patient Information in Periodontology: A Descriptive Pilot Study.Babayiğit, O., Ozkan Sen, D., Ucan Yarkac, F., Tastan Eroglu, Z.> ;Cureus. 2023 Nov 1
- 2 citationsPhase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follo...Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Karl D Lewis, Nicole Basset-Seguin, Anne Lynn S Chang, Stéphane Dalle, Almudena F...> ;Journal of the American Academy of Dermatology. 2024 Feb 1
- Join now to see all
Journal Articles
- Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell PopulationsZeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research
Lectures
- Retrospective analysis of patients with sentinel lymph node (SLN) positive melanoma (MEL) who received adjuvant nivolumab (NIVO) without completion lymph node dissecti...2019 ASCO Annual Meeting - 6/1/2019
- Phase I study of vemurafenib (VEM) and cobimetinib (COB) with heat shock protein 90 (HSP90) inhibitor XL888 in advanced BRAFV600 mutant melanoma.2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
Desmoplastic Melanoma Highly Responsive to ImmunotherapyMay 11th, 2023- Desmoplastic Melanoma Responds to Pembrolizumb MonotherapyApril 20th, 2023
- Woman's Breast Tumor Turned Out to Be Melanoma. But There Was Never a MoleMarch 13th, 2021
- Join now to see all
Hospital Affiliations
H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
